William H. Goo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
William H. Goo has a total of 32 co-authors. Here are the top co-authors by number of shared publications:
- Adam Bajinting
Division of Pediatric Surgery, SSM Health Cardinal Glennon Children’s Hospital, Saint Louis University School of Medicine, St. Louis, USA
3 shared publications - Brad W. Warner
Division of Pediatric Surgery, Department of Surgery, Washington University in St. Louis School of Medicine, St. Louis, MO 63110
2 shared publications Cathleen Courtney
Washington Univ, Sch Med, Dept Surg, Div Pediat Surg, St Louis, MO 63110 USA
2 shared publicationsJun Guo
Division of Pediatric Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, United States
2 shared publications- Kristen M. Seiler
Division of Pediatric Surgery, Department of Surgery, Washington University School of Medicine, St. Louis, Missouri, United States
2 shared publications Brad W. Warner
Division of Pediatric Surgery, Department of Surgery, Washington University School of Medicine in St. Louis, St. Louis, Missouri
1 shared publication
Latest Publications
- Open Access
- 2 March 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-14
Patient-derived small intestinal myofibroblasts direct perfused, physiologically responsive capillary development in a microfluidic Gut-on-a-Chip Model
The development and physiologic role of small intestine (SI) vasculature is poorly studied. This is partly due to a lack of targetable, organ-specific markers for in vivo studies of two critical tissue components: endothelium and stroma. This challenge is exacerbated by limitations of traditional cell culture techniques, which fail to recapitulate mechanobiologic stimuli known to affect vessel development. Here, we construct and characterize a 3D in vitro microfluidic model that supports the growth of patient-derived intestinal subepithelial myofibroblasts (ISEMFs) and endothelial cells (ECs) into perfused capillary networks. We report how ISEMF and EC-derived vasculature responds to physiologic parameters such as oxygen tension, cell density, growth factors, and pharmacotherapy with an antineoplastic agent (Erlotinib). Finally, we demonstrate effects of ISEMF and EC co-culture on patient-derived human intestinal epithelial cells (HIECs), and incorporate perfused vasculature into a gut-on-a-chip (GOC) model that includes HIECs. Overall, we demonstrate that ISEMFs possess angiogenic properties as evidenced by their ability to reliably, reproducibly, and quantifiably facilitate development of perfused vasculature in a microfluidic system. We furthermore demonstrate the feasibility of including perfused vasculature, including ISEMFs, as critical components of a novel, patient-derived, GOC system with translational relevance as a platform for precision and personalized medicine research.
- 2 March 2020
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-14
Open AccessPatient-derived small intestinal myofibroblasts direct perfused, physiologically responsive capillary development in a microfluidic Gut-on-a-Chip Model
The development and physiologic role of small intestine (SI) vasculature is poorly studied. This is partly due to a lack of targetable, organ-specific markers for in vivo studies of two critical tissue components: endothelium and stroma. This challenge is exacerbated by limitations of traditional cell culture techniques, which fail to recapitulate mechanobiologic stimuli known to affect vessel development. Here, we construct and characterize a 3D in vitro microfluidic model that supports the growth of patient-derived intestinal subepithelial myofibroblasts (ISEMFs) and endothelial cells (ECs) into perfused capillary networks. We report how ISEMF and EC-derived vasculature responds to physiologic parameters such as oxygen tension, cell density, growth factors, and pharmacotherapy with an antineoplastic agent (Erlotinib). Finally, we demonstrate effects of ISEMF and EC co-culture on patient-derived human intestinal epithelial cells (HIECs), and incorporate perfused vasculature into a gut-on-a-chip (GOC) model that includes HIECs. Overall, we demonstrate that ISEMFs possess angiogenic properties as evidenced by their ability to reliably, reproducibly, and quantifiably facilitate development of perfused vasculature in a microfluidic system. We furthermore demonstrate the feasibility of including perfused vasculature, including ISEMFs, as critical components of a novel, patient-derived, GOC system with translational relevance as a platform for precision and personalized medicine research.
- 27 February 2020
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 55 (6) , 1107-1112
Adaptation of extracellular matrix to massive small bowel resection in mice
- 27 February 2020
- Published by Elsevier in Journal of Pediatric Surgery
- Vol. 55 (6) , 1107-1112
Adaptation of extracellular matrix to massive small bowel resection in mice
- Open Access
- 1 January 2019
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 8 (3) , 407-426
Single-Cell Analysis Reveals Regional Reprogramming During Adaptation to Massive Small Bowel Resection in Mice
- 1 January 2019
- Published by Elsevier in Cellular and Molecular Gastroenterology and Hepatology
- Vol. 8 (3) , 407-426
Open AccessSingle-Cell Analysis Reveals Regional Reprogramming During Adaptation to Massive Small Bowel Resection in Mice